INTEGRATED ONCOLOGY NETWORK, LLC FORMS ALLIANCE WITH PHILIPS ELECTRONICS NORTH AMERICA CORPORATION

October 18, 2011

Corona del Mar, California - Integrated Oncology Network, LLC ("ION") today announced that it has entered into an exclusive alliance agreement with Philips Electronics North America Corporation, a subsidiary of Royal Philips Electronics (AEX: PHI, NYSE: PHG) ("Philips") to participate with the Philips Cancer Center Group, which will provide cancer center customers - including hospitals and owners and operators of outpatient radiation oncology centers - a robust solution for developing or enhancing a cancer center's competitiveness in the marketplace (the "Alliance"). ION intends to provide to the Alliance its radiation oncology management services, development services, capital, and other expertise.

"Together with Philips' leadership and innovation in cancer diagnosis and treatment planning, the Alliance will allow us to offer solutions that address the fundamental business and operational needs of cancer centers," said Jeffrey Goffman, chairman and CEO. "By giving clinicians and hospitals the support they need to align the business, financial, and management aspects of cancer care, they can get back to what matters most - quality patient care."

Grant Ingersoll, chief development officer and co-founder of ION, stated, "We are very excited to be an exclusive member of the Philips Cancer Center Group. We believe this initiative will provide great value to our collective companies and to many hospitals and doctors in need of these services to assure their competitiveness in today's oncology market."

About ION

ION, headquartered in Corona del Mar, California, is a radiation oncology management, development, and advisory firm that provides oncology solutions and capital for physician practices and hospitals who seek strategic, financial, and management expertise. ION's management team has expertise in assisting physicians with the formation of integrated oncology groups, which can enhance operational efficiencies and optimize utilization while continuing to focus on providing the best patient care. ION provides solutions for transactional services, project development for cancer centers, financing, and management services with expertise in radiation oncology operations, billing and collection, accounting, compliance, IT, M&A, physics and dosimetry, and other administrative services. ION provides liquidity for physician and hospital owners as it invests as a minority partner in radiation oncology centers with both physicians and hospitals. ION's management team has over 50 years of combined health care expertise, including working with several of the most prestigious oncology groups in the country as a trusted resource.

ION is a privately held company whose shareholders include a small group of strategic investors, including Capricorn Investment Group and Comvest Group.

For more information on ION, please visit our web site at www.ion-llc.com.

About Capricorn Investment Group

Capricorn Investment Group is a private, independent investment firm designed to be an ideal partner for clients desiring a global portfolio driven by consistent returns and underpinned by a principled philosophy. Capricorn currently manages approximately $5 billion through various investment strategies, which cover a range of areas, from long term, diversified global growth investment strategies, venture capital and private equity, credit strategies, and "clean and green" growth capital. Capricorn's investment philosophy is grounded in a strong fundamentals focused investment model, comprehensive research on long term, global mega-themes, such as energy, agriculture, transportation, consumer, health and wellness, technology, and consideration of business smart sustainability principles.

About Comvest Group

The Comvest Group is a leading private investment firm focused on providing debt and equity capital to lower middle-market companies. Our firm includes seasoned, senior level operating executives at all levels who partner with managers and owners of companies to grow businesses and create long-term value. Since 1988, Comvest has invested more than $2 billion of capital in over 200 public and private companies. For more information, please visit www.comvest.com.

Forward-Looking Statements

Statements in this Press Release that are not historical facts constitute "forward-looking statements." Any statements contained herein which are not historical facts or which contain the words "anticipate," "believe," "continue," "estimate," "expect," "intend," "may," "should," and similar expressions are intended to identify forward-looking statements. Such statements reflect the current view of ION with respect to future events and are subject to certain risks, uncertainties and assumptions, including, but not limited to, the risk that ION may not be able to implement its growth strategy in the intended manner, including the ability to identify, finance, complete joint venture opportunities, risks regarding currently unforeseen competitive pressures and risks affecting ION's industry, such as increased regulatory compliance and changes in regulatory requirements, changes in payor reimbursement levels. Should one or more of those risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein.

Forward-Looking Statements

Statements in this Press Release that are not historical facts constitute "forward-looking statements." Any statements contained herein which are not historical facts or which contain the words "anticipate," "believe," "continue," "estimate," "expect," "intend," "may," "should," and similar expressions are intended to identify forward-looking statements. Such statements reflect the current view of ION with respect to future events and are subject to certain risks, uncertainties and assumptions, including, but not limited to, the risk that ION may not be able to implement its growth strategy in the intended manner, including the ability to identify, finance, complete joint venture opportunities, risks regarding currently unforeseen competitive pressures and risks affecting ION's industry, such as increased regulatory compliance and changes in regulatory requirements, changes in payor reimbursement levels. Should one or more of those risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein.